The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development.

Ragu, C; Boukour, S; Elain, G; Wagner-Ballon, O; Raslova, H; Debili, N; Olson, E N; Daegelen, D; Vainchenker, W; Bernard, O A; Penard-Lacronique, V

Ragu, C; Boukour, S; Elain, G; Wagner-Ballon, O; Raslova, H; Debili, N; Olson, E N; Daegelen, D; Vainchenker, W; Bernard, O A; Penard-Lacronique, V.

Leukemia ; 24(6): 1227-30, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20428204

Subject(s)

Leukemia, Megakaryoblastic, Acute/pathology; Megakaryocytes/cytology; Megakaryocytes/metabolism; Serum Response Factor/physiology; Trans-Activators/physiology; Animals; Hematopoietic Stem Cells/cytology; Hematopoietic Stem Cells/metabolism; Integrases/metabolism; Mice; Mice, Knockout; Thrombocytopenia/etiology; Thrombocytopenia/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Megakaryocytes / Leukemia, Megakaryoblastic, Acute / Trans-Activators / Serum Response Factor Type of study: Etiology_studies Limits: Animals Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2010 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google